Detalhe da pesquisa
1.
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study.
Lancet Oncol
; 24(7): 772-782, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37276871
2.
Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma.
Ann Surg Oncol
; 30(5): 2782-2790, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36178565
3.
Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study.
BMC Cancer
; 23(1): 416, 2023 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37158833
4.
Perioperative and oncologic outcomes of laparoscopic versus open liver resection for combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis.
Surg Endosc
; 37(2): 967-976, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36076103
5.
CD74+ macrophages are associated with favorable prognosis and immune contexture in hepatocellular carcinoma.
Cancer Immunol Immunother
; 71(1): 57-69, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34009409
6.
Hazard rate for postoperative recurrence in patients with hepatocellular carcinoma at Barcelona Clinic Liver Cancer stage 0 or A1: A multicenter observational study.
Hepatol Res
; 52(11): 947-956, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35839151
7.
Understanding the patient experience in hepatocellular carcinoma: a qualitative patient interview study.
Qual Life Res
; 31(2): 473-485, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115280
8.
An mALBI-Child-Pugh-based nomogram for predicting post-hepatectomy liver failure grade B-C in patients with huge hepatocellular carcinoma: a multi-institutional study.
World J Surg Oncol
; 20(1): 206, 2022 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710377
9.
Future liver volume combined with platelet count predicts liver failure after major hepatectomy.
Surgeon
; 20(6): e416-e422, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35283025
10.
Increase of Portal Vein Pressure Gradient After Hepatectomy Predicts Post-operative Liver Dysfunction.
Surg Innov
; 29(2): 145-153, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33993786
11.
CircRNA UBAP2 serves as a sponge of miR-1294 to increase tumorigenesis in hepatocellular carcinoma through regulating c-Myc expression.
Carcinogenesis
; 42(10): 1293-1303, 2021 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34314478
12.
Cross talk between oxidative stress and hypoxia via thioredoxin and HIF-2α drives metastasis of hepatocellular carcinoma.
FASEB J
; 34(4): 5892-5905, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32157720
13.
Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?
Hepatobiliary Pancreat Dis Int
; 20(1): 13-20, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33160852
14.
Predicting overall survival of patients with hepatocellular carcinoma using a three-category method based on DNA methylation and machine learning.
J Cell Mol Med
; 23(5): 3369-3374, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30784182
15.
Lymphoid-specific helicase promotes the growth and invasion of hepatocellular carcinoma by transcriptional regulation of centromere protein F expression.
Cancer Sci
; 110(7): 2133-2144, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31066149
16.
An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
Oncologist
; 24(12): e1476-e1488, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31138726
17.
Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection.
BMC Cancer
; 19(1): 335, 2019 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30961559
18.
ASO Visual Abstract: Hepatectomy Following Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy in Patients with Unresectable Hepatocellular Carcinoma.
Ann Surg Oncol
; 30(5): 2791-2792, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869918
19.
Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B.
BMC Cancer
; 17(1): 58, 2017 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28095820
20.
Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression.
Hepatology
; 61(5): 1603-14, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25557975